This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2020 Oct 1;222(9):1417-1421.

doi: 10.1093/infdis/jiaa029.

Respiratory Syncytial Virus Antivirals: Problems and Progress

Frederick G Hayden¹, Richard J Whitley²

Affiliations

Affiliations

¹ Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
² Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.

PMID: 31974551
DOI: 10.1093/infdis/jiaa029

Editorial

Respiratory Syncytial Virus Antivirals: Problems and Progress

Frederick G Hayden et al. J Infect Dis. 2020.

. 2020 Oct 1;222(9):1417-1421.

doi: 10.1093/infdis/jiaa029.

Authors

Frederick G Hayden¹, Richard J Whitley²

Affiliations

¹ Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
² Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.

PMID: 31974551
DOI: 10.1093/infdis/jiaa029

No abstract available

Keywords: antivirals; respiratory syncytial virus; therapeutics.

PubMed Disclaimer

Comment on

Drug Resistance Assessment Following Administration of Respiratory Syncytial Virus (RSV) Fusion Inhibitor Presatovir to Participants Experimentally Infected With RSV.
Stray K, Perron M, Porter DP, Anderson F, Lewis SA, Perry J, Miller M, Cihlar T, DeVincenzo J, Chien JW, Jordan R. Stray K, et al. J Infect Dis. 2020 Oct 1;222(9):1468-1477. doi: 10.1093/infdis/jiaa028. J Infect Dis. 2020. PMID: 31971597 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information